DXDexCom DXCM · NASDAQ
$86.04 -1.90% (-$1.67)
- Market cap
- $33.1B
- Enterprise value
- $33.4B
- P/E
- 33.1x
- Forward P/E
- 32.5x
- PEG
- 0.9x
- P/S
- 6.7x
- P/FCF
- 23.6x
- EV/EBITDA
- 21.4x
- ROIC
- 21.6%
- Bruto marža
- 62.5%
- Neto marža
- 20.1%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 0.2x
- Beta
- 1.48
- Free float
- 99.6%
O podjetju
DexCom, Inc. (DXCM) is an American healthcare company specializing in the development and production of continuous glucose monitoring (CGM) systems for patients with diabetes. With innovative products like the Dexcom G6, DexCom provides accurate and continuous monitoring of blood sugar levels, allowing patients and healthcare professionals to better manage diabetes and improve quality of life. The company is known for its focus on technological innovations and continuous improvement of its products. DexCom also collaborates with other healthcare companies to integrate its CGM systems into broader healthcare ecosystems. DexCom, Inc. (DXCM) shares could be suitable for investors looking for opportunities in the medical technology sector with a focus on diabetes and innovations in health monitoring.
Sector
Healthcare
Industry
Medical - Devices
CEO
Jacob Steven Leach
Employees
11,050
Headquarters
San Diego
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke